You are here

What´s New


Welcome to the new website! Not sure how to log in?

User login

What's New

World Updates

Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia

Between 29 November and 17 December 2015, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 4 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, including 2 deaths. Globally, since September 2012, WHO has been notified of 1,625 laboratory-confirmed cases of infection with MERS-CoV, including at least 586 related deaths.

Zika virus infection – Panama

On 14 December 2015, the National IHR Focal Point (NFP) of Panama notified PAHO/WHO of one (1) additional laboratory-confirmed case of Zika virus infection. As of 17 December, 4 cases of Zika virus had been confirmed by reverse transcription polymerase chain reaction (RT-PCR). All laboratory-confirmed cases of Zika virus infection are female ranging in age between 25 and 59 years.

Zika virus infection – Cape Verde

On 21 October 2015, the National IHR Focal Point of Cape Verde informed WHO of the country’s first reported epidemic of Zika virus infection. On 5 October 2015, health centres in Praia, Santiago Island began to report cases of cutaneous rash and pruritus with and apparently without fever. The earliest onset of symptoms occurred on 27 September. As of 14 October, a total of 165 cases had been reported.

Zika virus infection – Honduras

On 16 December 2015, the Ministry of Health (MoH) of Honduras reported two (2) autochthonous cases of Zika virus infection. Both cases are male and residents of the southern area of Honduras. The cases were identified through active surveillance, and laboratory-confirmed by reverse transcription polymerase chain reaction (RT-PCR). The MoH called on the public to continue prevention and control activities, including vector control. The proximity of mosquito vector breeding sites to human habitation is a significant risk factor for Zika virus infection.

Circulating vaccine-derived poliovirus – Myanmar

The National IHR Focal Point of Myanmar has notified WHO of 2 cases of circulating vaccine-derived poliovirus type 2 (cVDPV2). Laboratory confirmation that VDPV type 2 is circulating in Myanmar was received on 7 November 2015. The circulating VDPV2 was isolated from a 16-month old boy who developed acute flaccid paralysis (AFP) on 5 October. The child had not been previously vaccinated against polio. This strain is from the same VDPV2 strain isolated earlier this year from a polio case (a 28-month-old child) that had developed AFP on 16 April.


Sign In Not a member? Register »

Remember me